Anti-inflammatory effects of progesterone in lipopolysaccharide-stimulated BV-2 microglia

PLoS ONE

Volumn 9, Issue 7, 2014, Pages

  Lei, Beilei ^a   Mace, Brian ^a   Dawson, Hana N ^a   Warner, David S ^a   Laskowitz, Daniel T ^a   James, Michael L ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOOXYGENASE 2; I KAPPA B ALPHA; INDUCIBLE NITRIC OXIDE SYNTHASE; LIPOPOLYSACCHARIDE; MIFEPRISTONE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; PROGESTERONE; PROGESTERONE RECEPTOR; STRESS ACTIVATED PROTEIN KINASE; SYNAPTOTAGMIN I; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR ALPHA; ANTIINFLAMMATORY AGENT; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NOS2 PROTEIN, MOUSE; PTGS2 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL CELL CULTURE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BV 2 CELL LINE; CELL LINE; CELL STIMULATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DOWN REGULATION; ENZYME PHOSPHORYLATION; IMMUNOFLUORESCENCE; MICROGLIA; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; UPREGULATION; WESTERN BLOTTING; ANIMAL; BIOSYNTHESIS; DRUG EFFECTS; DRUG SCREENING; FEMALE; IMMUNOLOGY; METABOLISM; PHOSPHORYLATION; PROTEIN PROCESSING; PROTEIN TRANSPORT;

ANIMALS; ANTI-INFLAMMATORY AGENTS; CELL LINE; CYCLOOXYGENASE 2; DRUG EVALUATION, PRECLINICAL; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FEMALE; LIPOPOLYSACCHARIDES; MICE; MICROGLIA; NF-KAPPA B; NITRIC OXIDE SYNTHASE TYPE II; PHOSPHORYLATION; PROGESTERONE; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEIN TRANSPORT; RECEPTORS, PROGESTERONE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84905220400     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0103969     Document Type: Article

References (52)

1. Vallee M, Mayo W, Darnaudery M, Corpechot C, Young J, et al. (1997) Neurosteroids: deficient cognitive performance in aged rats depends on low pregnenolone sulfate levels in the hippocampus. Proc Natl Acad Sci U S A 94: 14865-14870. (Pubitemid 28041466)
2. Wagner CK (2006) The many faces of progesterone: a role in adult and developing male brain. Front Neuroendocrinol 27: 340-359.
3. Brinton RD, Thompson RF, Foy MR, Baudry M, Wang J, et al. (2008) Progesterone receptors: form and function in brain. Front Neuroendocrinol 29: 313-339.
4. Singh M, Su C (2013) Progesterone and neuroprotection. Horm Behav 63: 284-290.
5. Mani S (2008) Progestin receptor subtypes in the brain: the known and the unknown. Endocrinology 149: 2750-2756.
6. Zhu Y, Hanna RN, Schaaf MJ, Spaink HP, Thomas P (2008) Candidates for membrane progestin receptors-past approaches and future challenges. Comp Biochem Physiol C Toxicol Pharmacol 148: 381-389.
7. Singh M, Su C, Ng S (2013) Non-genomic mechanisms of progesterone action in the brain. Front Neurosci 7: 159.
8. Mani SK, Oyola MG (2012) Progesterone signaling mechanisms in brain and behavior. Front Endocrinol (Lausanne) 3: 7.
9. Roof RL, Duvdevani R, Heyburn JW, Stein DG (1996) Progesterone rapidly decreases brain edema: treatment delayed up to 24 hours is still effective. Exp Neurol 138: 246-251. (Pubitemid 26132712)
10. Roof RL, Hoffman SW, Stein DG (1997) Progesterone protects against lipid peroxidation following traumatic brain injury in rats. Mol Chem Neuropathol 31: 1-11. (Pubitemid 27328632)
11. Pettus EH, Wright DW, Stein DG, Hoffman SW (2005) Progesterone treatment inhibits the inflammatory agents that accompany traumatic brain injury. Brain Res 1049: 112-119. (Pubitemid 40814581)
12. Robertson CL, Puskar A, Hoffman GE, Murphy AZ, Saraswati M, et al. (2006) Physiologic progesterone reduces mitochondrial dysfunction and hippocampal cell loss after traumatic brain injury in female rats. Exp Neurol 197: 235-243. (Pubitemid 41817236)
13. Cutler SM, Cekic M, Miller DM, Wali B, VanLandingham JW, et al. (2007) Progesterone improves acute recovery after traumatic brain injury in the aged rat. J Neurotrauma 24: 1475-1486. (Pubitemid 47493512)
14. Shahrokhi N, Khaksari M, Soltani Z, Mahmoodi M, Nakhaee N (2010) Effect of sex steroid hormones on brain edema, intracranial pressure, and neurologic outcomes after traumatic brain injury. Can J Physiol Pharmacol 88: 414-421.
15. Chen J, Chopp M, Li Y (1999) Neuroprotective effects of progesterone after transient middle cerebral artery occlusion in rat. J Neurol Sci 171: 24-30. (Pubitemid 29525574)
16. Kumon Y, Kim SC, Tompkins P, Stevens A, Sakaki S, et al. (2000) Neuroprotective effect of postischemic administration of progesterone in spontaneously hypertensive rats with focal cerebral ischemia. J Neurosurg 92: 848-852. (Pubitemid 30243934)
17. Cervantes M, Gonzalez-Vidal MD, Ruelas R, Escobar A, Morali G (2002) Neuroprotective effects of progesterone on damage elicited by acute global cerebral ischemia in neurons of the caudate nucleus. Arch Med Res 33: 6-14. (Pubitemid 34092265)
18. Morali G, Letechipia-Vallejo G, Lopez-Loeza E, Montes P, Hernandez-Morales L, et al. (2005) Post-ischemic administration of progesterone in rats exerts neuroprotective effects on the hippocampus. Neurosci Lett 382: 286-290. (Pubitemid 40733637)
19. Ishrat T, Sayeed I, Atif F, Stein DG (2009) Effects of progesterone administration on infarct volume and functional deficits following permanent focal cerebral ischemia in rats. Brain Res 1257: 94-101.
20. Dang J, Mitkari B, Kipp M, Beyer C (2011) Gonadal steroids prevent cell damage and stimulate behavioral recovery after transient middle cerebral artery occlusion in male and female rats. Brain Behav Immun 25: 715-726.
21. Gibson CL, Coomber B, Murphy SP (2011) Progesterone is neuroprotective following cerebral ischaemia in reproductively ageing female mice. Brain 134: 2125-2133.
22. Wang Z, Zuo G, Shi XY, Zhang J, Fang Q, et al. (2011) Progesterone administration modulates cortical TLR4/NF-kappaB signaling pathway after subarachnoid hemorrhage in male rats. Mediators Inflamm 2011: 848309.
23. Yan F, Hu Q, Chen J, Wu C, Gu C, et al. (2013) Progesterone attenuates early brain injury after subarachnoid hemorrhage in rats. Neurosci Lett 543: 163-167.
24. Wright DW, Kellermann AL, Hertzberg VS, Clark PL, Frankel M, et al. (2007) ProTECT: a randomized clinical trial of progesterone for acute traumatic brain injury. Ann Emerg Med 49: 391-402, 402 e391-392.
25. Xiao G, Wei J, Yan W, Wang W, Lu Z (2008) Improved outcomes from the administration of progesterone for patients with acute severe traumatic brain injury: a randomized controlled trial. Crit Care 12: R61.
26. Zhao X, Zhang Y, Strong R, Zhang J, Grotta JC, et al. (2007) Distinct patterns of intracerebral hemorrhage-induced alterations in NF-kappaB subunit, iNOS, and COX-2 expression. J Neurochem 101: 652-663. (Pubitemid 46633327)
27. Block ML, Zecca L, Hong JS (2007) Microglia-mediated neurotoxicity: uncovering the molecular mechanisms. Nat Rev Neurosci 8: 57-69. (Pubitemid 46011999)
28. Loane DJ, Byrnes KR (2010) Role of microglia in neurotrauma. Neurotherapeutics 7: 366-377.
29. Gomes-Leal W (2012) Microglial physiopathology: how to explain the dual role of microglia after acute neural disorders? Brain Behav 2: 345-356.
30. Marks-Konczalik J, Chu SC, Moss J (1998) Cytokine-mediated transcriptional induction of the human inducible nitric oxide synthase gene requires both activator protein 1 and nuclear factor kappaB-binding sites. J Biol Chem 273: 22201-22208. (Pubitemid 28399774)
31. D'Acquisto F, Iuvone T, Rombola L, Sautebin L, Di Rosa M, et al. (1997) Involvement of NF-kappaB in the regulation of cyclooxygenase-2 protein expression in LPS-stimulated J774 macrophages. FEBS Lett 418: 175-178. (Pubitemid 27514441)
32. Jang BC, Paik JH, Kim SP, Shin DH, Song DK, et al. (2005) Catalase induced expression of inflammatory mediators via activation of NF-kappaB, PI3K/AKT, p70S6K, and JNKs in BV2 microglia. Cell Signal 17: 625-633.
33. Bachstetter AD, Xing B, de Almeida L, Dimayuga ER, Watterson DM, et al. (2011) Microglial p38alpha MAPK is a key regulator of proinflammatory cytokine up-regulation induced by toll-like receptor (TLR) ligands or betaamyloid (Abeta). J Neuroinflammation 8: 79.
34. Bocchini V, Mazzolla R, Barluzzi R, Blasi E, Sick P, et al. (1992) An immortalized cell line expresses properties of activated microglial cells. J Neurosci Res 31: 616-621.
35. Henn A, Lund S, Hedtjarn M, Schrattenholz A, Porzgen P, et al. (2009) The suitability of BV2 cells as alternative model system for primary microglia cultures or for animal experiments examining brain inflammation. ALTEX 26: 83-94.
36. Burguillos MA, Deierborg T, Kavanagh E, Persson A, Hajji N, et al. (2011) Caspase signalling controls microglia activation and neurotoxicity. Nature 472: 319-324.
37. Nelson JF, Felicio LS, Osterburg HH, Finch CE (1992) Differential contributions of ovarian and extraovarian factors to age-related reductions in plasma estradiol and progesterone during the estrous cycle of C57BL/6J mice. Endocrinology 130: 805-810.
38. Gregersen R, Lambertsen K, Finsen B (2000) Microglia and macrophages are the major source of tumor necrosis factor in permanent middle cerebral artery occlusion in mice. J Cereb Blood Flow Metab 20: 53-65. (Pubitemid 30019830)
39. Lei B, Dawson HN, Roulhac-Wilson B, Wang H, Laskowitz DT, et al. (2013) Tumor necrosis factor alpha antagonism improves neurological recovery in murine intracerebral hemorrhage. J Neuroinflammation 10: 103.
40. Hehlgans T, Pfeffer K (2005) The intriguing biology of the tumour necrosis factor/tumour necrosis factor receptor superfamily: players, rules and the games. Immunology 115: 1-20. (Pubitemid 40598088)
41. Zhou Z, Peng X, Hagshenas J, Insolera R, Fink DJ, et al. (2010) A novel cell-cell signaling by microglial transmembrane TNFalpha with implications for neuropathic pain. Pain 151: 296-306.
42. Vallabhapurapu S, Karin M (2009) Regulation and function of NF-kappaB transcription factors in the immune system. Annu Rev Immunol 27: 693-733.
43. Ridder DA, Schwaninger M (2009) NF-kappaB signaling in cerebral ischemia. Neuroscience 158: 995-1006.
44. Hayden MS, Ghosh S (2008) Shared principles in NF-kappaB signaling. Cell 132: 344-362.
45. Xie QW, Kashiwabara Y, Nathan C (1994) Role of transcription factor NFkappa B/Rel in induction of nitric oxide synthase. J Biol Chem 269: 4705-4708. (Pubitemid 24239438)
46. Hardy DB, Janowski BA, Chen CC, Mendelson CR (2008) Progesterone receptor inhibits aromatase and inflammatory response pathways in breast cancer cells via ligand-dependent and ligand-independent mechanisms. Mol Endocrinol 22: 1812-1824.
47. Bhat NR, Zhang P, Lee JC, Hogan EL (1998) Extracellular signal-regulated kinase and p38 subgroups of mitogen-activated protein kinases regulate inducible nitric oxide synthase and tumor necrosis factor-alpha gene expression in endotoxin-stimulated primary glial cultures. J Neurosci 18: 1633-1641. (Pubitemid 28103071)
48. Zhang P, Hogan EL, Bhat NR (1998) Activation of JNK/SAPK in primary glial cultures: II. Differential activation of kinase isoforms corresponds to their differential expression. Neurochem Res 23: 219-225. (Pubitemid 28130627)
49. Bhat NR, Feinstein DL, Shen Q, Bhat AN (2002) p38 MAPK-mediated transcriptional activation of inducible nitric-oxide synthase in glial cells. Roles of nuclear factors, nuclear factor kappa B, cAMP response element-binding protein, CCAAT/enhancer-binding protein-beta, and activating transcription factor-2. J Biol Chem 277: 29584-29592. (Pubitemid 41079247)
50. Waetzig V, Czeloth K, Hidding U, Mielke K, Kanzow M, et al. (2005) c-Jun N-terminal kinases (JNKs) mediate pro-inflammatory actions of microglia. Glia 50: 235-246. (Pubitemid 40769853)
51. Taylor RA, Sansing LH (2013) Microglial responses after ischemic stroke and intracerebral hemorrhage. Clin Dev Immunol 2013: 746068.
52. Floden AM, Combs CK (2006) Beta-amyloid stimulates murine postnatal and adult microglia cultures in a unique manner. J Neurosci 26: 4644-4648. (Pubitemid 44315365)